Brown-Forman Corporation remains a Hold as Q1 results reinforce ongoing headwinds and limited near-term growth prospects. Organic sales declined 1% in Q1, with flat whiskey volumes and a 17% drop in Herradura Tequila net sales. Ready-to-drink category shows promise, but management expects gross margin to peak in Q1 and operating income to contract 3%-5% for FY27.
Brown-Forman Corporation (BF.B) Q1 2027 Earnings Call Transcript
Brown Forman NYSE: BF.A said its first-quarter fiscal 2027 results were largely in line with expectations, as growth from ready-to-drink products and Jack Daniel's Tennessee Blackberry helped offset pressure in used barrel sales, tequila and several developed international markets.
The whiskey giant's earnings per share outpace analysts' expectations; the company has contended with sluggish spirits market.
Brown Forman NYSE: BF.A shareholders re-elected the company's board and approved executive compensation and the auditor appointment at the spirits maker's 2026 Annual Meeting of Stockholders, held at Churchill Downs in Louisville, Kentucky.
Brown-Forman Corporation (BF.B) Shareholder/Analyst Call Prepared Remarks Transcript
Lawson Whiting, who has led the spirits giant since 2019, will remain in the role until a successor is appointed.
While Saturday's games will take place in the U.S., the excitement is mostly elsewhere, after the U.S. was knocked out of the tournament. Investors looking for a World Cup bump might be feeling similarly let down.
Brown-Forman is relying on emerging-market growth, premium spirits and innovation to offset weak developed-market demand and a cautious fiscal 2027 outlook.
Brown-Forman's Q4 EPS misses estimates, but sales beat on pricing and innovation led by Jack Daniel's Tennessee Blackberry amid a tough FY27 view.
Brown-Forman Corporation reported stable earnings in Q4. The performance is good when considering significant sector pressure in developed markets. Successful product launches, distribution changes, and better growth in emerging markets continue to drive Brown-Forman's relative strength. The FY2027 outlook isn't as good. Slowing alcohol consumption weighs on the sales outlook, and Brown-Forman will start to bottle more expensive inventory from early 2020s.
Brown-Forman is upgraded to Buy as its current valuation offers a solid margin of safety for a resilient, high-quality business. BF's stable cash flow and improved margins underscore robust capital allocation and operational strength, despite flat sales and macro headwinds. Management expects FY27 net sales to remain flat and organic operating income to decline 3–5%, but CAPEX will also drop significantly, supporting ongoing cost-saving initiatives.